News

Drug maker AstraZeneca to expand its manufacturing in US
AstraZeneca CEO Sir Pascal Soriot explains the reasoning behind its $50 billion expansion of operations across the U.S.
BioPharma Dive34m
AstraZeneca grows US presence with $50B in spending plans
The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...
AstraZeneca Vows to Spend $50 Billion on US Manufacturing, Development
AstraZeneca Plc plans to invest $50 billion in the US before 2030, becoming the latest European pharma company to ratchet up ...
EconoTimes1h
AstraZeneca Commits $50B to U.S. Expansion Amid Trump Tariff Push
AstraZeneca (NASDAQ: AZN) has unveiled plans to invest $50 billion in U.S. manufacturing and RD infrastructure by 2030, ...
Richmond Times-Dispatch3h
AstraZeneca picks Virginia for multibillion-dollar manufacturing site
The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
Business Facilities3h
AstraZeneca To Invest $50B In U.S. Drug Production, R&D
Virginia facility investment will be AstraZeneca’s largest yet. Maryland, Massachusetts, California, Indiana, Texas projects ...
Explore more
AstraZeneca to spend $50-billion to expand manufacturing, research capabilities in U.S.
Investment will fund drug manufacturing facility in Virginia and expand research and development and cell therapy ...
Fierce Pharma7h
AstraZeneca, facing lung cancer challenge from J&J, touts life extension benefit for Tagrisso combo
AstraZeneca is raising its defense against Johnson & Johnson in a fierce competition in EGFR-mutated non-small cell lung ...